# AMGEN hires BRAVO STRATEGY GROUP (Medical/Disease Research/Clinical Labs)

**Score:** 30/100

| Field | Value |
|---|---|
| Client | AMGEN |
| Client description | biotechnology manufacturing |
| Client state | DC |
| Lobbying firm | BRAVO STRATEGY GROUP |
| Firm state | DC |
| Issue areas | Medical/Disease Research/Clinical Labs |
| Specific matters disclosed | Biologics, biotechnology policies. |
| Registered | 2026-10-08 |

## Why this score


Source: U.S. Senate and House Lobbying Disclosure Act (LDA) filings via lda.gov; Colorado Secretary of State, NYC City Clerk eLobbyist and City of Chicago Board of Ethics lobbying data (https://lda.gov/filings/public/filing/7b07601b-ce88-427e-968e-13596fc0f4f0/print/). Last refreshed: 2026-11-03T19:42:41.566Z.
From public Lobbying Disclosure Act registrations (lda.gov) and Colorado, New York City and City of Chicago lobbying disclosures. Organization level only: we never list lobbyist, CEO or contact names, and clients whose name reads as a person are left out. Chicago amounts are lobbyist compensation reported for the quarter, summed by client. A registration reports intent to lobby; it is not evidence of wrongdoing.